Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pfizer

Pfizer
1849 FOUNDED
PUBLIC STATUS
90K-95K EMPLOYEES
PFE STOCK SYMBOL
87 INVESTMENTS
$38.22 SHARE PRICE (As of Wednesday Closing)
Description

Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total company sales.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Drug Discovery
Stock Exchange
NYS
Primary Office
  • 235 East 42nd Street
  • New York, NY 10017
  • United States

+1 (212) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Pfizer’s full profile, request a free trial.

Pfizer Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$33.97 - $44.90 $212B $38.48 $2.91 18.7M 5.53B

Pfizer Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 232,867,567 283,866,715 243,284,819 227,118,175
Revenue 53,039,000 53,647,000 52,546,000 52,824,000
EBITDA 25,761,000 19,252,000 19,453,000 14,824,000
Net Income 16,216,000 11,153,000 21,308,000 7,215,000
Total Assets 170,446,000 159,422,000 171,797,000 171,615,000
Total Debt 52,661,000 41,740,000 43,492,000 42,085,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pfizer Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Pfizer‘s full profile, request access.

Request full access to PitchBook

Pfizer Competitors (44)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merck & Co. Corporation Kenilworth, NJ 00000
0000000 & 0000000 Corporation New Brunswick, NJ 000000 0000
000000 Formerly VC-backed Cambridge, MA 0000 000.00 00000000000 000.00
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
00000000000 Formerly PE-Backed Cambridge, United Kingdom 00000 000 00000000 000
To view this company’s complete list of competitors, request access »

Pfizer Investments & Acquisitions (87)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 01-Aug-2019 00000 0000000 Pharmaceuticals 000 0000
00000 000000000 30-Jul-2019 000000000000000000 000.00 Biotechnology 000000 000000 00.0
00000 29-Jul-2019 000000000000000000 0000 Pharmaceuticals 000000 000000 00.0
000000000 01-Jul-2019 000000000000000000 00000 Drug Discovery 000000 0000000 00.0
GlaxoSmithKline (Consumer Healthcare Business) 24-May-2019 Secondary Transaction - Private Other Healthcare Services
To view this company’s complete investment and acquisition history, request access »

Pfizer Exits (22)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 04-Jan-2019 000000000 00000 Completed
  • 2 buyers
0000000 0000000000 01-Nov-2017 000000000 00000 Completed
  • 000000
00 000000 00000000 13-Dec-2016 000000000 Completed
  • 000000
00000000 000000000 04-Aug-2016 000 0000 Completed
  • 5 buyers
Gemphire Therapeutics 09-Mar-2016 Early Stage VC 000.00 Completed
  • 10 buyers
To view this company’s complete exits history, request access »

Pfizer Subsidiaries (22)

Company Name Industry Location Founded
Bamboo Therapeutics Biotechnology Chapel Hill, NC 2014
0000000000 Pharmaceuticals Piscataway Township, NJ 0000
0000000 000(0) 000 Corporate Pension Peapack, NJ 0000
0000000 Medical Supplies Lake Forest, IL 0000
000000 00000000 Corporate Venture Capital New York, NY 0000
To view this company’s complete subsidiary history, request access »

Pfizer Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Pfizer‘s full profile, request access.

Request full access to PitchBook

Pfizer Executive Team (314)

Name Title Board
Seat
Contact
Info
Albert Bourla Ph.D Chief Executive Officer & Board Member
Mikael Dolsten Ph.D Chief Scientific Officer & President
John Young Executive & President
Mike Gladstone Global President of Internal Medicine for Pfizer Innovative Health
Michael Goettler President

82 Former Executives

You’re viewing 5 of 314 executives. Get the full list »

Pfizer Board Members (16)

Name Representing Role Since Contact
Info
000000 000000 00.0 Pfizer Chief Executive Officer & Board Member 000 0000
00000 0000000 Pfizer Director, Portfolio Director & Planning Lead, PMP, Pfizer Oncology 000 0000
000000 00000000 00 Pfizer Board Member 000 0000
00000 00000 Pfizer Board Member 000 0000
000 0000 Pfizer Chairman & Board Member 000 0000

5 Former Board Members

You’re viewing 5 of 16 board members. Get the full list »